[HTML][HTML] LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619 …
C Zhou, C Yi, Y Yi, W Qin, Y Yan, X Dong, X Zhang… - Molecular cancer, 2020 - Springer
Background Pancreatic cancer is one of the most lethal malignancies and has an extremely
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 …
C Zhou, C Yi, Y Yi, W Qin, Y Yan, X Dong… - Molecular …, 2020 - europepmc.org
Background Pancreatic cancer is one of the most lethal malignancies and has an extremely
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 …
C Zhou, C Yi, Y Yi, W Qin, Y Yan, X Dong… - Molecular …, 2020 - search.ebscohost.com
Background: Pancreatic cancer is one of the most lethal malignancies and has an extremely
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
[PDF][PDF] LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p …
C Zhou, C Yi, Y Yi, W Qin, Y Yan, X Dong, X Zhang… - 2020 - scienceopen.com
Background: Pancreatic cancer is one of the most lethal malignancies and has an extremely
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
[PDF][PDF] LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p …
C Zhou, C Yi, Y Yi, W Qin, Y Yan, X Dong, X Zhang… - 2020 - scholar.archive.org
Background: Pancreatic cancer is one of the most lethal malignancies and has an extremely
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
[HTML][HTML] LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619 …
C Zhou, C Yi, Y Yi, W Qin, Y Yan, X Dong… - Molecular …, 2020 - ncbi.nlm.nih.gov
Background Pancreatic cancer is one of the most lethal malignancies and has an extremely
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
[HTML][HTML] LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619 …
C Zhou, C Yi, Y Yi, W Qin, Y Yan… - Molecular …, 2020 - molecular-cancer.biomedcentral …
Pancreatic cancer is one of the most lethal malignancies and has an extremely poor
diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 …
C Zhou, C Yi, Y Yi, W Qin, Y Yan, X Dong… - Molecular …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Pancreatic cancer is one of the most lethal malignancies and has an extremely
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/[beta]-catenin and autophagy pathway through modulating the miR-619-5p …
C Zhou, C Yi, Y Yi, W Qin, Y Yan, X Dong, X Zhang… - Molecular …, 2020 - go.gale.com
Background Pancreatic cancer is one of the most lethal malignancies and has an extremely
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 …
C Zhou, C Yi, Y Yi, W Qin, Y Yan, X Dong… - Molecular …, 2020 - search.proquest.com
Background Pancreatic cancer is one of the most lethal malignancies and has an extremely
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …
poor diagnosis and prognosis. The development of resistance to gemcitabine is still a major …